Form 4: Evolent Health Director Peter Grua Acquires Restricted Stock Units

Director Peter J. Grua of Evolent Health, Inc. reports acquisition of restricted stock units and changes in beneficial ownership.

Summary

• Peter J. Grua, a director at Evolent Health, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On June 6, 2024, Grua acquired 7,709 shares of Class A Common Stock as restricted stock units.
• These restricted stock units were granted under the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
• The shares vest on the earlier of June 6, 2025, or the date of the company's 2025 annual meeting, contingent upon Grua's continued service.
• Following the transaction, Grua directly owns 12,758 shares of Class A Common Stock.
• Grua also indirectly owns 36,870 shares through the Peter J. Grua 2004 Revocable Trust, for which he is the sole trustee with sole voting and dispositive power.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing indicating standard compensation practices. It doesn't contain information that would drastically shift investor sentiment.

Positives

• The acquisition of restricted stock units aligns the director's interests with the company's long-term performance.
• The vesting schedule incentivizes continued service and commitment from the director.

Future Outlook

The director's continued service is tied to the vesting of the restricted stock units, suggesting an ongoing commitment to the company.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The acquisition of restricted stock units by a director can reassure shareholders of the director's alignment with the company's success.

Key Dates